Concepedia

Corinne Vandermeulen

CV

48

Publications

2.8K

Citations

29

H-Index

1999

Active since

Affiliations

KU Leuven(Current)

University of Antwerp

Ghent University Hospital

GlaxoSmithKline (Belgium)

Rega Institute for Medical Research

Corinne Vandermeulen is an author at KU Leuven specializing in vaccination, medicine, and vaccine safety.

ORCID

Top concepts

Publications per year

1999–2023

48

Publications

48

Recombinant gp350 Vaccine for Infectious Mononucleosis: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of an Epstein‐Barr Virus Vaccine in Healthy Young Adults

Étienne Sokal, Karel Hoppenbrouwers, Corinne Vandermeulen et al. · The Journal of Infectious Diseases · 2007 · 413 citations · Full text

Sexual maturation in relation to polychlorinated aromatic hydrocarbons: Sharpe and Skakkebaek's hypothesis revisited.

Elly Den Hond, Harry A. Roels, Karel Hoppenbrouwers et al. · Environmental Health Perspectives · 2002 · 224 citations · Full text

A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate

Lorena Sánchez-Felipe, Thomas Vercruysse, Sapna Sharma et al. · Nature · 2020 · 184 citations · Full text

Outbreak of mumps in a vaccinated child population: a question of vaccine failure?

Corinne Vandermeulen, Mathieu Roelants, Marijke Vermoere et al. · Vaccine · 2004 · 124 citations

, , +9

An Adjuvanted, Low‐Dose, Pandemic Influenza A (H5N1) Vaccine Candidate Is Safe, Immunogenic, and Induces Cross‐Reactive Immune Responses in Healthy Adults

Karin Levie, Isabel Leroux‐Roels, Karel Hoppenbrouwers et al. · The Journal of Infectious Diseases · 2008 · 117 citations · Full text

Rows per page

1–5 of 48